Related Experiment Videos
Isodicentric X chromosome in myeloproliferative disorders
P Temperani1, P Zucchini, G Emilia
1Second Medical Clinic, University of Modena, Italy.
Acta Haematologica
|January 1, 1989
Summary
Two cases of acquired isodicentric X chromosome (idic(X)(q13)) in myeloproliferative disorders were identified. This late-replicating abnormal X chromosome suggests a cellular selective advantage in these conditions.
Area of Science:
- Cytogenetics
- Hematology
- Molecular Biology
Background:
- Myeloproliferative disorders (MPDs) are a group of clonal hematopoietic stem cell malignancies.
- Chromosomal abnormalities are frequently observed in MPDs and can influence disease progression and prognosis.
- The role of specific chromosomal alterations, such as isodicentric X chromosomes, in MPDs requires further investigation.
Observation:
- Two patients with MPDs presented with an acquired isodicentric X chromosome, specifically idic(X)(q13).
- One patient was diagnosed with primary myelofibrosis, and the other with chronic myelogenous leukemia.
- DNA replication studies confirmed that both abnormal X chromosomes were late replicating in all examined cells.
Findings:
- The acquired isodicentric X chromosome (idic(X)(q13)) was consistently late replicating.
- This finding suggests that the idic(X)(q13) chromosome may be inactivated or transcriptionally silent.
- The presence of this specific chromosomal abnormality was observed in distinct MPD subtypes.
Implications:
- The late-replicating nature of idic(X)(q13) implies a potential selective advantage for cells carrying this alteration.
- This selective advantage could contribute to clonal expansion and disease progression in myeloproliferative disorders.
- Further research into the functional consequences of idic(X)(q13) in MPDs is warranted to understand its role in pathogenesis.